NRX Pharmaceuticals, Inc. Increase (Decrease) in Prepaid Taxes
NRX Pharmaceuticals, Inc. (NRXP) reported Increase (Decrease) in Prepaid Taxes of $0 for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidTaxes · last filed 2021-05-21
- NRX Pharmaceuticals, Inc. increase (decrease) in prepaid taxes for the quarter ending 2021-03-31 was $0.00.
- NRX Pharmaceuticals, Inc. increase (decrease) in prepaid taxes for the quarter ending 2020-12-31 was $5.36K, a 92.29% decline year-over-year.
- NRX Pharmaceuticals, Inc. increase (decrease) in prepaid taxes for the quarter ending 2020-09-30 was $42.69K.
- NRX Pharmaceuticals, Inc. increase (decrease) in prepaid taxes for the quarter ending 2020-06-30 was $3.60K.
- NRX Pharmaceuticals, Inc. increase (decrease) in prepaid taxes for fiscal 2020 was -$17.84K, a 125.68% decline from fiscal 2019.
- NRX Pharmaceuticals, Inc. increase (decrease) in prepaid taxes for fiscal 2019 was $69.48K.
- NRX Pharmaceuticals, Inc. increase (decrease) in prepaid taxes for fiscal 2018 was $0.00.
| Period end | Increase (Decrease) in Prepaid Taxes 3 month | Increase (Decrease) in Prepaid Taxes 6 month | Increase (Decrease) in Prepaid Taxes 9 month | Increase (Decrease) in Prepaid Taxes 12 month |
|---|---|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-21 | $5.36K derived: sum of 2 quarters · filed 2021-05-21 | $48.05K derived: sum of 3 quarters · filed 2021-05-21 | $51.64K derived: sum of 4 quarters · filed 2021-05-21 |
| 2020-12-31 | $5.36K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-14 | $48.05K derived: sum of 2 quarters · filed 2021-05-14 | $51.64K derived: sum of 3 quarters · filed 2021-05-14 | -$17.84K 10-K/A · filed 2021-05-14 |
| 2020-09-30 | $42.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $46.29K derived: sum of 2 quarters · filed 2020-11-16 | -$23.20K 10-Q · filed 2020-11-16 | $46.29K derived: sum of 4 quarters · filed 2021-05-21 |
| 2020-06-30 | $3.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$65.89K 10-Q · filed 2020-08-14 | $3.60K derived: sum of 3 quarters · filed 2021-05-21 | $3.60K derived: sum of 4 quarters · filed 2021-05-21 |
| 2020-03-31 | -$69.48K 10-Q · filed 2021-05-21 | $0.00 derived: sum of 2 quarters · filed 2021-05-21 | $0.00 derived: sum of 3 quarters · filed 2021-05-21 | $0.00 derived: sum of 4 quarters · filed 2021-05-21 |
| 2019-12-31 | $69.48K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-14 | $69.48K derived: sum of 2 quarters · filed 2021-05-14 | $69.48K derived: sum of 3 quarters · filed 2021-05-14 | $69.48K 10-K/A · filed 2021-05-14 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-15 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |